This issue brings together 2025 research and clinical highlights spanning Magstim TMS and EGI EEG, including peer-reviewed studies, videos, clinical features, webinars, events, product launches and awards.

Each monthly edition features curated summaries with direct links to read the research, watch expert insights and explore how neurotechnology is advancing care and discovery worldwide.

Ronnie Stolec-Campo, CEO of Welcony, said, “Across clinics, labs and hospitals worldwide, clinicians and researchers share a common goal: to better understand the brain and improve care. The research, stories and videos in this newsletter represent just a small glimpse of the hundreds of studies, treatments and breakthroughs happening every year.”

Inside this issue, you’ll find:

• EEG and TMS research shaping our understanding of the brain
• Clinical applications improving outcomes in real-world settings
• Direct links to dozens of studies, stories and videos from across 2025

Featured highlights include:

• New EEG study: Noninvasive biomarkers for assessing the excitatory/inhibitory imbalance in children with epilepsy
• New TMS study: Longitudinal single-pulse TMS in infants with perinatal brain injury: safety and feasibility
• New video: TMS system review from Dr. Thomas Hughes, sharing clinical insights on Magstim Horizon TMS systems
• EEG feature: Research from Bruce C. Hansen of Colgate University exploring how brain-augmented AI reveals the neural dynamics behind perception
• Magstim Rapid webinar: A deep dive into the enhanced capabilities of the FDA-cleared Magstim Rapid TMS Research System
• New EGI article: Advantages of high-density EEG for training AI and machine-learning models
• TMS webinar: Clinical insights into TMS for chronic pain
• TMS deep-dive video: Highlights from iTalk TMS founder Kyle Hartfield, recorded at the Clinical TMS Society Annual Meeting in San Diego
• LIVE launch video: Coverage from the unveiling of the new EGI Geodesic EEG System 500 (GES 500)—a transformative HD-EEG platform designed to advance brain research, precision stimulation and patient care

Magstim EGI electroencephalography (EEG) and transcranial magnetic stimulation (TMS) technologies have more than 30 years of history and are used in 100+ regions worldwide. Together, these technologies have been cited in more than 20,000 peer-reviewed research papers, supporting both discovery and clinical translation.

Looking ahead, 2026 is shaping up to be an especially exciting year for neurotechnology researchers and clinicians, particularly those working to advance brain research and care for patients and adolescents with major depressive disorder (MDD). Innovation in EEG, TMS and combined approaches continues to accelerate—bringing new insight, precision and hope to brain health.

At Welcony, and across our global family of TMS and EEG brands, the Magstim EGI team is honored to support clinicians and researchers worldwide with trusted neurotechnology, collaboration and partnership as you work to improve lives.

Read the full January Newsletter: Scan the QR code or visit: http://6470370.hs-sites.com/new-magstim-egi-tms-eeg-research-clinical-newsletter-2025-in-review-3

To learn more, visit www.magstim.com or email marketing@magstim.com to request additional information, arrange a demonstration or receive a system quote.